Field Trip

Field Trip is a company that offers psychedelic therapies. It has several locations (US/CA) that provides ketamine-assisted therapy. It has raised $19.5M in Series A & B funding rounds.

In March 2021, Field Trip announced it closed a bought deal short form prospectus offering at a value of $76 million. 

Field Trip

“Field Trip Health is a new kind of mental wellness company. We offer a deeply human experience that combines the science of psychedelic medicine with personal psychotherapy and wellness practices. Our doctors and therapists are disrupting the mental health landscape and redefining the way we approach depression and mental health issues.”

The company is working on a variety of different arms related to psychedelics. This included a clinic, app, and original research. The latter is now working on FT-104, a patentable molecule (phase I planned in Q3 2021). By developing a new molecule, they may be able to sidestep the legal hassles associated with (known) psychedelics. In a mini-interview with Psilocybin Alpha, the company says the drug will have a half-life of 1/3rd (so about 1,5-2 hours) compared to psilocybin and can be administered orally or via injection.

Since October 2020 the company is listed on the Canadian Securities Exchange (CSE). The company was also funded (in part) by Synaptic Ventures.

Field Trip also hosts a podcast about psychedelics, named Field Tripping.

Heroic Hearts has partnered with Field Trip to raise awareness and provide insurance-covered ketamine treatment at Field Trips clinics.

They recently also launched an app to be used during a trip, called trip.

Key Staff

  • Joseph del Moral – Founder & CEO
  • Ronan Levy – Founder & Executive Chairman
  • Hannan Fleiman – Founder & President of Healthcare Practice
  • Mujeeb Jaffeir – Founder & President
  • Ryan Yermus – Founder & Chief Clinical Officer
  • Nathan Bryson – CSO
  • Amardeep Manhas – CTO
  • Andrew Weil – advisor


Company Information

Field Trip Website

April, 2019


B2B B2C Drug Discovery Clinic

Topics of Interest

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships

Related Course(s)

DB101: How to Use Psychedelics to Heal
DB101: How to Use Psychedelics is a comprehensive course that covers everything you need to know to get the most out of your journey with these powerful medicines, including how to choose the right psychedelic for you, where to access safe, legal psychedelics, and how to integrate the lessons of your trip once it’s over.

Company News

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies (GlobeNewswire, 28 May 2022)

The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (Motherboard, 24 January 2022)
This article, by the always excellent Shayla Love, discussed the next generation of novel psychedelics. Starting with the many discoveries of Sasha Shulgin, the article then dives deeper into the wishes and hopes of psychedelic companies.


HQ / Office 30 Duncan St Suite 400, Toronto, ON M5V 2C3, Canada
Clinic 109 Malcolm X Blvd, New York, NY 10026, USA
Clinic 1538 20th St 2nd floor, Santa Monica, CA 90404, USA
Clinic 325 W Huron St Suite 603, Chicago, IL 60654, USA
Clinic 750 Glenwood Ave SE Building 200 Suite 210, Atlanta, GA 30316, USA
Clinic 4310 Westheimer Rd Suite 220, Houston, TX 77027, USA
Clinic Piet Heinkade 55, 1019 GM Amsterdam, Netherlands
Clinic 1875 El Prado, San Diego, CA 92101, USA